A Retrospective Comparative Analysis of Distraction Osteogenesis and Spring-Mediated Cranioplasty for Posterior Cranial Vault Expansion in Patients with Multisutural Craniosynostosis
The Cleft Palate Craniofacial Journal · 06.08.2026
DOI: 10.1177/10556656261474918 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Cleft Palate Craniofacial Journal, online erschienen am 06.08.2026. Verfasst von Trey D Watmore und 5 weiteren Autor:innen. Beteiligte Einrichtung: Phoenix Children's Center for Cleft and Craniofacial Care, Division of Plastic, Reconstructive, and Maxillofacial Surgery, Phoenix Children's, Phoeni…. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Objective
To compare perioperative outcomes, complications, imaging utilization, and device management following posterior vault distraction osteogenesis (PVDO) and spring-mediated cranioplasty (SMC) for multisutural craniosynostosis.
Design
Retrospective cohort study.
Setting
Single pediatric tertiary care center. Patients, Participants Twenty-three patients with multisutural craniosynostosis treated between 2017 and 2025 (PVDO, n = 18; SMC, n = 5).
Interventions
PVDO or SMC. Main Outcome Measure(s) Time to device removal, imaging utilization, reoperations, readmissions, device-related complications, revision surgeries, wound infections, and absolute intracranial volume change.
Results
PVDO was associated with earlier device removal than SMC (78.7 ± 22.1 vs. 133.0 ± 27.4 days; P = .0015) but greater postoperative imaging utilization during the first year (5.33 ± 1.28 vs. 2.80 ± 1.64 studies; P = .01). Rates of reoperation (22.2% vs. 0%), readmission (22.2% vs. 40.0%), device-related complications (11.1% vs. 0%), revision surgery (16.7% vs. 0%), and wound infection (22.2% vs. 20.0%) did not differ significantly (all P ≥ .50). Preoperative imaging utilization and postoperative intracranial volume gain were comparable between groups.
Conclusions
PVDO and SMC demonstrated similar safety profiles and intracranial volume expansion in patients with multisutural craniosynostosis. Compared with SMC, PVDO enabled earlier device removal but required increased postoperative imaging. These findings may inform operative planning, postoperative surveillance, and family counseling. Larger, multicenter studies with longer follow-up are needed to evaluate long-term outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Phoenix Children's Center for Cleft and Craniofacial Care, Division of Plastic, Reconstructive, and Maxillofacial Surgery, Phoenix Children's, Phoenix, AZ, USA.
- Office of Research, Biostatistics, Phoenix Children's, Phoenix, AZ, USA.
- Division of Radiology, Phoenix Children's, Phoenix, AZ, USA.
- Department of Child Health, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA.
- Division of Plastic Surgery, Mayo Clinic, Scottsdale, AZ, USA.
ORCID-Profile: Trey D Watmore, Austin Grove, Andrew Ritchey, Cory Pfeifer
Zitieren
APA
Watmore, T. D., Grove, A., Ritchey, A., Pfeifer, C., Kurnik, N., & Singh, D. J. (2026). A Retrospective Comparative Analysis of Distraction Osteogenesis and Spring-Mediated Cranioplasty for Posterior Cranial Vault Expansion in Patients with Multisutural Craniosynostosis. The Cleft Palate Craniofacial Journal. https://doi.org/10.1177/10556656261474918
Vancouver
Watmore TD, Grove A, Ritchey A, Pfeifer C, Kurnik N, Singh DJ. A Retrospective Comparative Analysis of Distraction Osteogenesis and Spring-Mediated Cranioplasty for Posterior Cranial Vault Expansion in Patients with Multisutural Craniosynostosis. The Cleft Palate Craniofacial Journal. 2026. doi:10.1177/10556656261474918
BibTeX
@article{Watmore2026,
author = {Watmore, Trey D and Grove, Austin and Ritchey, Andrew and Pfeifer, Cory and Kurnik, Nicole and Singh, Davinder J},
title = {A Retrospective Comparative Analysis of Distraction Osteogenesis and Spring-Mediated Cranioplasty for Posterior Cranial Vault Expansion in Patients with Multisutural Craniosynostosis},
journal = {The Cleft Palate Craniofacial Journal},
year = {2026},
doi = {10.1177/10556656261474918}
}
EUVIMED